These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 1540929

  • 1. Influences of sphingosine on two-stage skin tumorigenesis in Sencar mice.
    Enkvetchakul B, Barnett T, Liotta DC, Geisler V, Menaldino D, Merrill AH, Birt DF.
    Cancer Lett; 1992 Feb 14; 62(1):35-42. PubMed ID: 1540929
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of skin carcinomas but not papillomas by sphingosine, N-methylsphingosine, and N-acetylsphingosine.
    Birt DF, Merrill AH, Barnett T, Enkvetchakul B, Pour PM, Liotta DC, Geisler V, Menaldino DS, Schwartzbauer J.
    Nutr Cancer; 1998 Feb 14; 31(2):119-26. PubMed ID: 9770723
    [Abstract] [Full Text] [Related]

  • 3. Hyperthermia and phorbol ester tumor promotion in mouse skin.
    Mitchel RE, Morrison DP, Gragtmans NJ, Jevcak JJ.
    Carcinogenesis; 1986 Sep 14; 7(9):1505-10. PubMed ID: 3091284
    [Abstract] [Full Text] [Related]

  • 4. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
    Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH.
    Carcinogenesis; 1993 Nov 14; 14(11):2353-8. PubMed ID: 8242866
    [Abstract] [Full Text] [Related]

  • 5. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
    Verma AK, Boutwell RK.
    Carcinogenesis; 1980 Mar 14; 1(3):271-6. PubMed ID: 22283009
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
    Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH.
    Cancer Res; 1994 Feb 01; 54(3):701-8. PubMed ID: 8306331
    [Abstract] [Full Text] [Related]

  • 7. Vitamin E is a complete tumor promoter in mouse skin.
    Mitchel RE, McCann R.
    Carcinogenesis; 1993 Apr 01; 14(4):659-62. PubMed ID: 8472330
    [Abstract] [Full Text] [Related]

  • 8. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH.
    APMIS Suppl; 1994 Apr 01; 41():1-38. PubMed ID: 7946481
    [Abstract] [Full Text] [Related]

  • 9. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of DMBA-induced mouse skin tumorigenesis by garlic oil and inhibition of two tumor-promotion stages by garlic and onion oils.
    Perchellet JP, Perchellet EM, Belman S.
    Nutr Cancer; 1990 Dec 15; 14(3-4):183-93. PubMed ID: 2128117
    [Abstract] [Full Text] [Related]

  • 11. The reverse experiment in two-stage skin carcinogenesis. It cannot be genuinely performed, but when approximated, it is not innocuous.
    Iversen OH.
    APMIS Suppl; 1993 Dec 15; 34():1-96. PubMed ID: 8251199
    [Abstract] [Full Text] [Related]

  • 12. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
    Skarin T, Rozell BL, Bergman J, Toftgård R, Möller L.
    Chem Biol Interact; 1999 Sep 30; 122(2):89-106. PubMed ID: 10528995
    [Abstract] [Full Text] [Related]

  • 13. Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse.
    Birt DF, White LT, Choi B, Pelling JC.
    Cancer Res; 1989 Aug 01; 49(15):4170-4. PubMed ID: 2472874
    [Abstract] [Full Text] [Related]

  • 14. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
    Slaga TJ.
    Environ Health Perspect; 1986 Sep 01; 68():27-32. PubMed ID: 3096709
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice.
    Wei H, Tye L, Bresnick E, Birt DF.
    Cancer Res; 1990 Feb 01; 50(3):499-502. PubMed ID: 2105157
    [Abstract] [Full Text] [Related]

  • 16. Acceleration of papilloma growth in mice fed high-fat diets during promotion of two-stage skin carcinogenesis.
    Birt DF, Pelling JC, Tibbels MG, Schweickert L.
    Nutr Cancer; 1989 Feb 01; 12(2):161-8. PubMed ID: 2496398
    [Abstract] [Full Text] [Related]

  • 17. Effects of short-term exposure to the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate on skin carcinogenesis in SENCAR mice.
    Diwan BA, Ward JM, Henneman J, Wenk ML.
    Cancer Lett; 1985 Mar 01; 26(2):177-84. PubMed ID: 3919937
    [Abstract] [Full Text] [Related]

  • 18. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW, Conti CJ, Phillips JL, Slaga TJ, DiGiovanni J.
    J Natl Cancer Inst; 1989 May 03; 81(9):676-82. PubMed ID: 2496233
    [Abstract] [Full Text] [Related]

  • 19. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH, Conti CJ, DiGiovanni J.
    Cancer Res; 1987 Jul 15; 47(14):3783-90. PubMed ID: 3109733
    [Abstract] [Full Text] [Related]

  • 20. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
    DiGiovanni J, Walker SE, Aldaz CM, Slaga TJ, Conti CJ.
    Carcinogenesis; 1993 Sep 15; 14(9):1831-6. PubMed ID: 8403206
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.